Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00387062 | Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment | completed | Phase 1 | 50 | Posit Science CorporationINDUSTRY | 1 | Jun 24, 2008 | clinicaltrials |
| NCT00150917 |
| RCT of a Group Intervention for Women With a Family History of Breast Cancer |
| completed |
| Phase 3 |
| 150 |
| University Health Network, TorontoOTHER |
| 1 |
| Jun 17, 2008 |
| clinicaltrials |
| NCT00093002 | Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer | completed | Phase 2 | 179 | AstraZenecaINDUSTRY | 6 | Jun 12, 2008 | clinicaltrials |
| NCT00212082 | Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer | completed | Phase 2 | 100 | National University Hospital, SingaporeOTHER | 1 | Jun 12, 2008 | clinicaltrials |
| NCT00302120 | The MONET - Study: MR Mammography of Nonpalpable Breast Tumors(MONET) | unknown | Phase 4 | 440 | UMC UtrechtOTHER | 1 | Jun 10, 2008 | clinicaltrials |
| NCT00386087 | Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy | completed | Phase 2 | 41 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 6, 2008 | clinicaltrials |
| NCT00530101 | The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity | completed | Phase 1 | 3 | University of MiamiOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00173290 | Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00159094 | A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer | unknown | Phase 2 | 30 | Hematology Oncology ConsultantsOTHER | 1 | Jun 2, 2008 | clinicaltrials |
| NCT00687778 | 11C-Acetate PET/CT Non-FDG-Avid Tumors | unknown | — | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 2, 2008 | clinicaltrials |
| NCT00688337 | Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer | unknown | — | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 2, 2008 | clinicaltrials |
| NCT00380952 | Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure | completed | N/A | 300 | Dune Medical DevicesINDUSTRY | 1 | May 28, 2008 | clinicaltrials |
| NCT00201435 | Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC | completed | Phase 2 / Phase 3 | 224 | Norwegian Breast Cancer GroupOTHER | 1 | May 20, 2008 | clinicaltrials |
| NCT00117910 | Treatment for Elderly Patients With High Risk Breast Cancer | completed | Phase 3 | — | AmgenINDUSTRY | 0 | May 16, 2008 | clinicaltrials |
| NCT00430001 | Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer | unknown | Phase 3 | 300 | Danish Breast Cancer Cooperative GroupOTHER | 1 | May 9, 2008 | clinicaltrials |
| NCT00434369 | 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients | unknown | Phase 2 | 31 | Mast Therapeutics, Inc.INDUSTRY | 5 | Apr 22, 2008 | clinicaltrials |
| NCT00575354 | Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor Excision(CSIABTEC) | completed | Phase 4 | 500 | Nanjing Medical UniversityOTHER | 1 | Apr 21, 2008 | clinicaltrials |
| NCT00589901 | An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC) | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Apr 18, 2008 | clinicaltrials |
| NCT00655447 | Examining the Long-Term Risks of Oophorectomy | completed | — | 32,175 | Parker, William H., M.D.OTHER | 1 | Apr 9, 2008 | clinicaltrials |
| NCT00461344 | Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer | terminated | Phase 2 | 20 | SanofiINDUSTRY | 0 | Apr 3, 2008 | clinicaltrials |
| NCT00249301 | A Study of MLN8054 in Patients With Advanced Solid Tumors | terminated | Phase 1 | 63 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00286247 | Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer | completed | Phase 2 | 60 | Introgen TherapeuticsINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00649337 | Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons | unknown | N/A | 4,650 | SonoCine, Inc.INDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00146029 | Companion Pharmacogenetic Study to UMCC 9900/9901 | terminated | — | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 26, 2008 | clinicaltrials |
| NCT00641628 | Nipple Areola Complex Conservation | completed | — | — | Technical University of MunichOTHER | 1 | Mar 24, 2008 | clinicaltrials |
| NCT00638391 | Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer(Ax-003) | completed | — | 1,600 | AstraZenecaINDUSTRY | 0 | Mar 20, 2008 | clinicaltrials |
| NCT00195026 | Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection | completed | — | 200 | Weill Medical College of Cornell UniversityOTHER | 1 | Mar 18, 2008 | clinicaltrials |
| NCT00001193 | A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer | completed | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001239 | Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001250 | Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial | completed | Phase 2 | 130 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001269 | Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer | completed | Phase 1 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001270 | Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma | completed | Phase 1 | 85 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001302 | A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001338 | A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer | completed | Phase 3 | 65 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001378 | A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001383 | A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001385 | Positron Emission Tomography in Patients With Breast Cancer | completed | — | 75 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001440 | Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy | completed | Phase 1 | 51 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001444 | A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms | completed | Phase 1 | 51 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001468 | Outcomes of Education and Counseling for BRCA1 Testing | completed | — | 1,500 | National Human Genome Research Institute (NHGRI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001496 | Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer | completed | — | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001504 | A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001805 | A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001837 | Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients | completed | — | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001944 | Vinorelbine and XR9576 to Treat Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026949 | Study of Etoposide in Breast Cancer Patients | completed | — | 33 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
Data updated 24 days agoSource updated Jul 15, 2008source: clinicaltrials